IO Biotech, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
IO Biotech, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • IO Biotech, Inc. Return On Equity for the quarter ending September 30, 2024 was -86.6 %, a 42.1% decline year-over-year.
  • IO Biotech, Inc. annual Return On Equity for 2023 was -66.3 %, a 52.7% decline from 2022.
  • IO Biotech, Inc. annual Return On Equity for 2022 was -43.4 %, a 98.3% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -86.6 -25.7 -42.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -70.1 -13.3 -23.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -69.3 -20.9 -43.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -66.3 -22.9 -52.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -60.9 -21.2 -53.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -56.8 -7.13 -14.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -48.4 +84.4 +63.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.4 +2.54K +98.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -39.8 Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -133 Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.59K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.